Antiemetic Management in Massive Mixed Overdose: Prioritize Airway, Avoid Polypharmacy

Airway and Breathing Take Absolute Priority

In massive mixed overdoses (opioid, benzodiazepine, GHB) the foremost threat is respiratory depression and loss of airway protection; establishing a patent airway and providing ventilatory support is the cornerstone of care. American Heart Association (2023) cardiac‑arrest/poisoning guideline. 2
Naloxone should be administered promptly for opioid‑induced respiratory depression; withholding it because it may trigger vomiting is contraindicated, as untreated respiratory failure is immediately life‑threatening. AHA guideline. 2
Flumazenil is contraindicated in mixed‑agent overdoses because it can precipitate seizures in patients with benzodiazepine tolerance, co‑ingestion of pro‑convulsant drugs, or underlying seizure disorders. AHA guideline. 2

A total domperidone dose of 50 mg (5 mg × 10) is 2.5 × the standard single dose (20 mg) used for gastroparesis, representing an excessive exposure in acute poisoning. Annals of Oncology (2005). 3
A total ondansetron dose of 16 mg (4 mg × 4) is double the maximum recommended single dose (8 mg) for acute nausea, exceeding safe limits. Annals of Oncology (2005). 3
Aprepitant 240 mg (120 mg × 2) equals two full chemotherapy loading doses; the standard regimen for highly emetogenic chemotherapy is 125 mg on day 1 followed by 80 mg on subsequent days. Journal of Clinical Oncology (2011). 5
These dosing recommendations are derived from chemotherapy‑induced nausea and vomiting (CINV) protocols, which are not applicable to acute toxic ingestions where the pathophysiology and risk‑benefit balance differ markedly. Journal of Clinical Oncology (2011). 5

Domperidone and metoclopramide are dopamine‑antagonist antiemetics that can cause central nervous system depression, drowsiness, and sedation, thereby compounding the CNS depressant effects of the ingested opioids, benzodiazepines, and GHB. Annals of Oncology (2005). 3
Aprepitant has no therapeutic role in acute poisoning and is indicated only for CINV; using it adds unnecessary drug exposure without benefit. Journal of Clinical Oncology (2011). 5

When the patient is alert, airway‑protected, and experiencing intractable vomiting that interferes with oral activated charcoal or causes severe distress, a single low‑dose ondansetron 4 mg IV is preferred because it provides effective anti‑emesis with minimal CNS side‑effects compared with dopamine antagonists. Praxis Medical Insights (2026). 4

Never prioritize anti‑emetic therapy over airway management in patients with massive CNS‑depressant overdose. AHA guideline. 2
Never apply chemotherapy anti‑emetic regimens (high‑dose domperidone, ondansetron, aprepitant, multi‑drug combinations) to acute poisoning cases. Journal of Clinical Oncology (2011). 5
Never combine multiple sedating anti‑emetics (e.g., dopamine antagonists) in an obtunded patient, as additive CNS depression increases the risk of respiratory failure. Annals of Oncology (2005). 3
Never suppress vomiting indiscriminately; in an alert patient, vomiting may reduce drug absorption and is preferable to the risk of aspiration that accompanies forced gag‑reflex suppression. Journal of Clinical Oncology (2011). 5